Substantial Portion Of Investor Claims In Biotech Company Stock-Drop Suit Remain

Mealey's (February 18, 2021, 2:04 PM EST) -- PHILADELPHIA — A federal judge in Pennsylvania on Feb. 16 ruled that shareholders in a securities class action lawsuit against a biotechnology company and three of its senior executives have sufficiently...
To view the full article, register now.